Harbor Human Capital Factor US Small Cap ETF (ARCA: HAPS)

Dernières nouvelles pour Harbor Human Capital Factor US Small Cap ETF (ARCA:HAPS)

Financial Services

Technology

Healthcare

Industrials

Consumer Cyclical

Real Estate

Energy

Consumer Defensive

Basic Materials

Other

Utilities

Communication Services

The Fund employs an indexing investment approach designed to track the performance of the Index. The Fund invests at least 80% of its total assets in securities that are included in the Index.

Blueprint Medicines Corp

Phillips Edison & Company Inc.

Armstrong World Industries Inc

Moog Inc

Avnet Inc

Apple Hospitality REIT Inc

Cabot Corp

Kosmos Energy, Ltd

National Storage Affiliates Trust

Grand Canyon Education Inc

Brinker International Inc Common Stock Usd 0.1

Ptc Therapeutics Inc

Dutch Bros Inc

Invesco S&p Smallcap Energy Etf

Allete Inc

Haemonetics

Inventrust Properties Corp

Radian Group Inc

Invesco S&P Smallcap Financials Etf

Piper Sandler Companies

Rhythm Pharmaceuticals Inc

Kratos Defense & Security Solutions, Inc.

Harbor Human Capital Factor US Small Cap ETF

WIIM

LakeShore Biopharma shares are trading higher after the company announced a $15 million private placement financing.

News

BCTX

BriaCell Reports 52% One-Year Survival in Phase 2 Metastatic Breast Cancer Trial, Surpassing Standard of Care in Heavily Pre-Treated Patients

Financing

LakeShore Biopharma Enters $15M Share And Warrant Purchase Agreement With Institutional Investor

Martin Marietta  Appoints Michael J. Petro as Chief Financial Officer, Succeeding Interim CFO Robert J. Cardin Effective Immediately

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

SLNH

Soluna Holdings Announces 30 MW Expansion With A Bitcoin Miner At Dorothy 2 Site

NDRA: 156% &#x7C; <a href="https://www.benzinga.com/node/46285134">ENDRA Life Sciences shares are trading higher after the company announced it will be granted a US patent titled "Radio Frequency Applicator".</a>
&nbsp;
PROK: 158% &#x7C; <a href="https://www.benzinga.com/node/46292228">ProKidney shares are trading higher after the company reported statistically and clinically significant topline results from its Phase 2 REGEN-007 trial evaluating Rilparencel in patients with chronic kidney disease and diabetes.</a>
&nbsp;
LASE: 51% &#x7C; <a href="https://www.benzinga.com/node/46285555">Laser Photonics shares are trading higher after the company reported a year-over-year increase in Q1 revenue results.</a>

Movers

Trading Ideas

LASE

NDRA

PROK

Market-Moving News for July 8th

Colliers Securities analyst Barry Oxford initiates coverage on Bluerock Homes Trust (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BHM#AMEX">BHM</a>) with a Buy rating and announces Price Target of $15.

Price Target

Initiation

Analyst Ratings

Bluerock Homes Trust, Inc. Class A Common Stock

Colliers Securities Initiates Coverage On Bluerock Homes Trust with Buy Rating, Announces Price Target of $15

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates UroGen Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) with a Buy and maintains $50 price target.

Reiteration

URGN

HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $50 Price Target

Biotech

General

PSTV

Plus Therapeutics Announces Treatment Of Initial Patients In ReSPECT-LM Dose Optimization Trial Of REYOBIQ In Leptomeningeal Metastases

Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) reported a sharp rise in <a target="_blank" href="https://www.benzinga.com/topic/alibaba" rel="noreferrer noopener">on-demand delivery transactions</a>, with combined daily orders on its platforms, Taobao Instant Commerce and Ele.me, reaching 80 million. This information was shared in a Monday post on Alibaba&#8217;s official WeChat account, <a target="_blank" href="https://www.scmp.com/tech/big-tech/article/3317275/taobaos-daily-demand-orders-soar-chinas-instant-e-commerce-war-heats" rel="noreferrer noopener">as</a> reported by the South China Morning Post.
Taobao Instant Commerce, launched in late April, gained traction quickly. It hit 10 million daily orders in its first week and 40 million within a month, then jumped from 60 to 80 million in just 12 days amid summer promotions and subsidies.
The platform&#8217;s daily active users have now surpassed 200 million, signaling Alibaba&#8217;s intensified efforts to compete with rivals like Meituan (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MPNGF#OTC">MPNGF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MPNGY#OTC">MPNGY</a>) and JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) in the rapidly expanding instant delivery market.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/asia/25/06/46091793/chinas-food-delivery-war-heats-up-as-jd-com-recruits-thousands-of-full-time-riders" rel="noreferrer noopener">China&#8217;s Food Delivery War Heats Up As JD.com Recruits Thousands Of Full-Time Riders</a>
In the ongoing competition, Meituan, a major player in the food delivery sector, reported 120 million daily transactions on Saturday, leading to brief server overloads as food and retail order volumes peaked during high-demand periods. Meituan maintains a steady hold on its 70% market share in domestic food delivery.
Alibaba&#8217;s strategic push into on-demand delivery is further evidenced by its commitment of a 50 billion yuan (approximately $7 billion) subsidy program for consumers and merchants over the next year. This program is designed to accelerate growth beyond Alibaba&#8217;s traditional e-commerce business.
To streamline operations and enhance its competitive edge against Meituan and JD.com, Alibaba integrated Ele.me and Fliggy into its <a target="_blank" href="https://www.benzinga.com/markets/asia/25/06/46047699/alibaba-integrates-ele-me-and-fliggy-into-core-business-to-battle-rivals-in-delivery-war" rel="noreferrer noopener">core e-commerce unit</a> in June.
Analysts from Jefferies told the SCMP that Alibaba now focuses on integrating food delivery, instant commerce, and traditional retail to maximize synergies across segments.
Alibaba stated that the rapid expansion of Taobao Instant Commerce has contributed to a doubling of China&#8217;s total daily instant delivery orders across different platforms from around 100 million in May to 200 million.
Investors have shown optimism, pushing Alibaba and other Chinese stocks higher on Tuesday, largely in anticipation of the upcoming U.S. tariff deadline.
According to a report from Elara <a target="_blank" href="https://www.cnbctv18.com/market/stocks/global-investors-are-flocking-to-chinese-stocks-ahead-of-us-tariffs-deadline-19632525.htm" rel="noreferrer noopener">cited</a> by CNBC, Chinese equities saw $2.4 billion in inflows last week alone. This trend is part of a larger pattern, with emerging market funds attracting over $6 billion in the past three weeks, marking the fastest inflow pace since January 2023.
President Donald Trump had initially set a July 9 deadline for various countries to finalize trade deals to avoid higher tariff rates. However, the White House confirmed that President Trump will sign an executive order to delay this deadline to August 1, 2025. This three-week reprieve is intended to allow more time for trade negotiations, as the administration aims to secure favorable trade deals.
Price Action:&nbsp;BABA shares are trading higher by&nbsp;2.40% to&nbsp;$108.82 premarket at&nbsp;last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46250853/alibabas-ai-and-cloud-moves-have-sparked-28-stock-rebound" target="_blank" rel="noreferrer noopener">Alibaba&#8217;s AI And Cloud Moves Have Sparked 28% Stock Rebound</a></li>
</ul>
Photo by Robert Way via Shutterstock

Asia

Tech

Media

BABA

MPNGF

MPNGY

Alibaba's Delivery Ambition Sets Stage For China's Epic Clash Of Giants

HC Wainwright &amp; Co. analyst Mitchell Kapoor reiterates Legend Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGN#NASDAQ">LEGN</a>) with a Buy and maintains $75 price target.

LEGN

HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $75 Price Target

MBAV

Trading Halt: Halted at 7:27:20 a.m. ET - Trading Halt: Halt News Pending

MBAVW

MBAVU

WestPark Capital analyst Casey Ryan initiates coverage on Data I/O (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAIO#NASDAQ">DAIO</a>) with a Buy rating and announces Price Target of $5.22.

DAIO

WestPark Capital Initiates Coverage On Data I/O with Buy Rating, Announces Price Target of $5.22

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the information technology sector.
<h3 class="wp-block-heading">HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 4.58%</li>
<li>UBS analyst David Vogt maintained a Neutral rating and cut the price target from $37 to $26 on May 29, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Citigroup analyst Asiya Merchant maintained a Neutral rating and slashed the price target from $29 to $27.5 on May 29, 2025. This analyst has an accuracy rate of 79%.</li>
<li>Recent News: On May 28, HP reported worse-than-expected second-quarter adjusted EPS results and issued third-quarter adjusted EPS guidance below estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0708">latest HPQ news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0708"><img loading="lazy" decoding="async" width="912" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065636/image-74.png" alt="" class="wp-image-976317" style="width:601px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065636/image-74.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065636/image-74-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065636/image-74-768x696.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 3.68%</li>
<li>Mizuho analyst Vijay Rakesh maintained a Neutral rating and raised the price target from $72 to $75 on July 1, 2025. This analyst has an accuracy rate of 77%.</li>
<li>Barclays analyst Tom O'Malley maintained an Underweight rating and increased the price target from $45 to $52 on May 8, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On May 29, Skyworks Solutions named Robert Schriesheim as interim CFO.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0708">latest SWKS news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="910" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065719/image-75.png" alt="" class="wp-image-976319" style="width:586px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065719/image-75.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065719/image-75-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065719/image-75-768x694.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></figure>
<h3 class="wp-block-heading">Infosys Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 2.76%</li>
<li>Stifel analyst David Grossman maintained a Hold rating and cut the price target from $18 to $17 on April 21, 2025. This analyst has an accuracy rate of 66%.</li>
<li>BMO Capital analyst Keith Bachman maintained a Market Perform rating and slashed the price target from $25 to $18 on April 21, 2025. This analyst has an accuracy rate of 82%.</li>
<li>Recent News: On June 18, Infosys and Adobe announced a strategic collaboration to jointly transform the marketing life cycle of global brands with AI. </li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0708">INFY news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0708"><img loading="lazy" decoding="async" width="902" height="808" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065805/image-76.png" alt="" class="wp-image-976323" style="width:604px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065805/image-76.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065805/image-76-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08065805/image-76-768x688.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li>T<a href="https://www.benzinga.com/markets/equities/25/07/46289573/trump-tariffs-sink-dow-over-400-points-investor-sentiment-declines-but-fear-greed-index-remains-in-extreme-greed-zone">rump Tariffs Sink Dow Over 400 Points: Investor Sentiment Declines, But Fear &amp; Greed Index Remains In &#8216;Extreme Greed&#8217; Zone</a></li>
</ul>

Long Ideas

Dividends

Pre-Market Outlook

INFY

SWKS

Wall Street's Most Accurate Analysts Spotlight On 3 Tech Stocks Delivering High-Dividend Yields

Endeavour Silver Produces 2.5M AgEq Oz in Q2 2025, Driven by Kolpa Integration; Silver Output Hits 1.48M Oz, Gold at 7,755 Oz

HC Wainwright &amp; Co. analyst Sean Lee maintains Senseonics Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SENS#AMEX">SENS</a>) with a Buy and raises the price target from $1.1 to $1.4.

SENS

HC Wainwright & Co. Maintains Buy on Senseonics Holdings, Raises Price Target to $1.4

Brookdale Reports June 2025 Occupancy Rise: Month-End Consolidated Rate Hits 82.2%, Up 230 bps YoY And 70 bps Sequentially

D. Boral Capital analyst Jason Kolbert maintains ImmunityBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) with a Buy and maintains $30 price target.

IBRX

D. Boral Capital Maintains Buy on ImmunityBio, Maintains $30 Price Target

Comments

Harbor Human Capital Factor US Small Cap ETF

Actualités

Dernières nouvelles pour Harbor Human Capital Factor US Small Cap ETF (ARCA:HAPS)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL